A Strain Change Study for SARS-CoV-2 rS Vaccines
NCT06409663
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Interventions
BIOLOGICAL:
NVX-CoV2705 Vaccine
Sponsor
Novavax